---
title: "VRDN.US (VRDN.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/VRDN.US/news.md"
symbol: "VRDN.US"
name: "VRDN.US"
parent: "https://longbridge.com/en/quote/VRDN.US.md"
datetime: "2026-06-13T23:36:53.633Z"
locales:
  - [en](https://longbridge.com/en/quote/VRDN.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/VRDN.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/VRDN.US/news.md)
---

# VRDN.US (VRDN.US) — Related News

### [How Investors May Respond To Viridian Therapeutics (VRDN) Debt Repayment And WuXi Manufacturing Pact](https://longbridge.com/en/news/288151479.md)
*2026-05-30T17:18:44.000Z*
> Viridian Therapeutics fully repaid ~$55.1M debt and secured a WuXi Biologics manufacturing pact for veligrotug, signalin

### [Viridien: Availability of the preparatory documents for the Combined General Meeting | CGG Stock News](https://longbridge.com/en/news/286233695.md)
*2026-05-13T01:40:27.000Z*
> Viridien: Availability of the preparatory documents for the Combined General Meeting | CGG Stock News

### [Viridien: Information on the total number of voting rights and shares  | CGG Stock News](https://longbridge.com/en/news/286126383.md)
*2026-05-12T07:30:29.000Z*
> Viridien: Information on the total number of voting rights and shares | CGG Stock News

### [Barclays Releases a Buy Rating on Viridien (0RI9)](https://longbridge.com/en/news/285664430.md)
*2026-05-08T03:25:36.000Z*
> Barclays analyst Mick Pickup has assigned a Buy rating to Viridien (0RI9), with shares closing at €113.20. The analyst c

### [Viridien (0RI9) Receives a Rating Update from a Top Analyst](https://longbridge.com/en/news/285652079.md)
*2026-05-08T02:05:48.000Z*
> Kepler Capital analyst Kevin Roger has maintained a Buy rating on Viridien (0RI9) with a price target of €180.00, while 

### [Viridian Therapeutics Announces Pricing of Upsized Concurrent Public Offerings of 1.75% Convertible Senior Notes Due 2032 and Common Stock with Aggregate Gross Proceeds of $350.0 Million | VRDN Stock News](https://longbridge.com/en/news/285477473.md)
*2026-05-06T19:15:32.000Z*
> Viridian Therapeutics Announces Pricing of Upsized Concurrent Public Offerings of 1.75% Convertible Senior Notes Due 203